Obesity Economy Disruption

Long-term use of GLP-1 drugs is reshaping consumer behavior, with many users reporting reduced visits to fast food restaurants and decreased snacking. As the obesity economy faces potential losses, analysts predict a $25 billion hit to the restaurant industry by 2025. The ripple effects could extend beyond food, influencing sectors like fitness and apparel as consumer spending habits evolve.